StockpollyBeta
Get App
Popularity #3,367
GLPG · NASDAQ · Biotechnology

Galapagos (ADR) (GLPG)

Belgian biotech shifting from cell therapy toward partnered immunology and oncology assets.

$27.98
vs last close+0.47 (+1.71%)
No recent trading data

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue137−238718968868574811,026714
Cost of revenue6963190129165121511
Gross profit130−238687068−437069691,02523
165−159106113130292511343491617456
Research & development114−818284106653208109841223530
96−1003518534750213934026
Selling & marketing78−983−21085−43−330
General & administrative19−2322043394526367370
Other expenses−4622−1111−29−672−8422635−10
Operating income−34−79−38−43−62−71−181−65−281864−73−52
64864486933−5428288854
Interest income0322927262114110000
Interest expense0000001027100
Other non-operating income−68−5−64−112112−212050−5522600
Income before tax29−71265−5622−178−119−252892162
Income tax expense0−4−1−1−10−20−20100
Net income from continuing operations29−66275−5522−176−119−232891162
Discontinued operations00765−271−12010
Other adjustments02460000000000
Net income2917910310−5729−175−120−230891172
EPS, basic$0.44$2.72$1.56$0.16−$0.84$0.33−$2.65−$1.83−$3.53$13.53$0.25$0.03
EPS, diluted$0.44$2.72$1.56$0.16−$0.84$0.33−$2.65−$1.83−$3.53$13.53$0.25$0.03
Weighted average shares, basic666666666667666665666670
Weighted average shares, diluted666666666667666666666670
EBITDA34−742689−174−61−181−115−216638−73−52
Depreciation & amortization000210100010000
EBIT34−742669−174−71−181−115−225638−73−52